Company intelligence / Profile preview
Beijing No. 1 Biochemical Pharmaceutical
Beijing, Beijing Shi, China1bp.com.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Beijing No. 1 Biochemical Pharmaceutical is a long-established Chinese pharmaceutical company specializing in the development, manufacturing, and sale of biochemical drugs such as spleen aminopeptide, thymosin, and thrombin—the first to be developed and produced domestically. The company has completed a Phase 4 clinical trial for spleen aminopeptide oral solution targeting seasonal allergic rhinitis in children.
- Therapeutic areas
- HematologyImmunology
- Modalities
- Small moleculeProtein
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Received support from China Development Bank for development finance.
Beyond the preview
Go deeper on Beijing No. 1 Biochemical Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing No. 1 Biochemical Pharmaceutical.